Today
-0.59%
5 Days
-17.54%
1 Month
-11.14%
6 Months
+11.96%
Year to Date
-11.46%
1 Year
-45.68%
Unitedhealth Group Inc's fundamentals are relatively healthy, with industry-average ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 61 out of 76 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 398.27.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Media Coverage
UnitedHealth Group Incorporated is an American multinational for-profit organization that specializes in health insurance and healthcare services, located in Eden Prairie, Minnesota. Operating under the UnitedHealthcare brand for insurance products and the Optum brand for healthcare services, it is recognized as the world's seventh-largest company by revenue and the largest healthcare corporation by revenue. The company ranks 8th on the 2024 Fortune Global 500 list, with a market capitalization of $460.3 billion as of December 20, 2024. UnitedHealth Group has encountered numerous investigations, lawsuits, and penalties—including SEC enforcement related to stock option backdating, Medicare overbilling, unfair claims practices, denials of mental health treatments, and anticompetitive conduct—illuminating deep-rooted issues of fraud, patient harm, and corporate misconduct.
UnitedHealth Group Stock Analysis: Why has UNH's stock price halved this year? Should investors follow Buffett's lead and continue holding? Will UNH's stock price hit new lows?

TradingKey - As US tech stocks grapple with AI bubble concerns and faltering performance, quarterly 13F filings from investment institutions are entering a heavy disclosure period. These reports will unveil "smart money" strategies and could influence future market direction. However, given recent

TradingKey - The Dow Jones Industrial Average has reached successive record highs, and its outperformance against the Nasdaq over the past two days reached the highest level in nine months, signaling an early market style shift from tech to blue-chip or value stocks amid persistent concerns about

Key PointsOne pundit tracking the stock became less bullish on its future.He knocked down his price target by 37%.10 stocks we like better than UnitedHealth Group › What the stock analysis community giveth, it can also taketh away.That was the dynamic behind the slide of UnitedHealth Group...
.jpg)
TradingKey - In Q2 2025, the value of Berkshire Hathaway’s investment portfolio declined from $259.8 billion in Q1 to $257.5 billion, a decrease of 0.89%. Analysis indicates that this drop is primarily driven by a net capital outflow of 0.78%. The outflow may be linked to changing market conditions

UnitedHealth Group (NYSE: UNH) has been one of the more interesting case studies in the stock market this year. Many stocks that have witnessed plummeting share prices can point to President Donald Trump's new tariff policies as the culprit.
.jpg)


UnitedHealth Group Incorporated is an American multinational for-profit organization that specializes in health insurance and healthcare services, located in Eden Prairie, Minnesota. Operating under the UnitedHealthcare brand for insurance products and the Optum brand for healthcare services, it is recognized as the world's seventh-largest company by revenue and the largest healthcare corporation by revenue. The company ranks 8th on the 2024 Fortune Global 500 list, with a market capitalization of $460.3 billion as of December 20, 2024. UnitedHealth Group has encountered numerous investigations, lawsuits, and penalties—including SEC enforcement related to stock option backdating, Medicare overbilling, unfair claims practices, denials of mental health treatments, and anticompetitive conduct—illuminating deep-rooted issues of fraud, patient harm, and corporate misconduct.
Related Instruments
Popular Symbols